Lyribea Capsule 25mg (Pregabalin)

Adult dose

This medication is taken orally, divided into 2 doses daily, with or without food. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg per day, may increase to 300 mg per day after 3 to 7 days, and can be further increased up to 600 mg at 7-day intervals as needed. - Central neuropathic pain: Starting dose of 150 mg per day, may increase to 300 mg per day after one week.

Child dose

The use of this medication is not recommended in children under 12 years old and adolescents aged 12 to 17, as there is insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behavior, so patients should be closely monitored for mood changes or depressive symptoms while taking it. Patients allergic to this medication's components should not take it. Diabetic patients may need to adjust their blood sugar control medications due to weight gain. If symptoms of angioedema such as swelling around the face or mouth occur, discontinue use immediately. Elderly patients should be particularly cautious when starting treatment, as dizziness or drowsiness can increase the risk of falls. Transient blurred vision or visual changes may occur, which can improve upon discontinuation of the medication. When stopping this medication, withdrawal symptoms such as insomnia, headache, and anxiety may occur, so patients should consult their healthcare provider. Patients with a history of substance abuse should use this medication with caution due to a high risk of misuse or dependence. Patients with impaired kidney function may require dosage adjustments. Patients with severe heart conditions should exercise caution when using this medication. Due to its central nervous system depressant effects, using this medication alongside opioid analgesics may lead to increased respiratory depression or drowsiness, so care must be taken. Pregnant women should avoid this medication during early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. Women who are breastfeeding should consider discontinuing breastfeeding or stopping the medication as it may be passed into breast milk. Patients should exercise caution in dangerous activities such as driving or operating machinery as dizziness or drowsiness may occur after taking this medication. If severe skin rashes or allergic symptoms occur while taking this medication, discontinue use immediately and inform healthcare providers. In the event of an overdose, symptoms such as confusion, drowsiness, and depression may occur, and treatment such as hemodialysis may be necessary. This medication should be kept out of the reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), tightness in the chest, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in the oral/conjunctival mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination abnormalities

Mild side effects

• Dizziness
• drowsiness
• confusion
• disturbance in spatial orientation
• irritability
• depression
• elation
• decreased sexual desire
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to keep it in a cool place between 15 to 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a long time.

Appearance

A hard capsule with a light yellow upper part and a white lower part filled with a white or light yellow powder

Package unit

30 capsules/bottle, 100 capsules/bottle